Skip to main content
Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.3690
+0.0202 (5.79%)
At close: Jun 4, 2025, 4:00 PM
0.3600
-0.0090 (-2.44%)
After-hours: Jun 4, 2025, 7:42 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Antibody-drug Conjugates
40.50M
Log In
Log In
Log In
Log In
Upgrade
Antibody-drug Conjugates Growth
9.88%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
40.50M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
9.88%
Log In
Log In
Log In
Log In
Upgrade